More than 2.2 billion vaccinations against COVID-19 were given to Chinese residents as part of a mass vaccination campaign, according to the State Health Committee of the People’s Republic of China.
“As of September 26, 31 regions of China reported the use of 2 billion 200 million 202 thousand vaccinations against COVID-19,” the ministry said in a statement published on its website.
Earlier it was reported that as of September 18, the number of Chinese residents vaccinated with at least one dose of the COVID-19 vaccine exceeded 1.1 billion, of which 1.02 billion people were fully vaccinated. At the same time, it was not specified how many country residents were vaccinated with this or that vaccine.
Zhong Nanshan, China’s leading expert on respiratory diseases, previously stated that China plans to vaccinate 80% of the population against coronavirus by the end of the year. According to the latest census, more than 1.4 billion people live in mainland China.
The Chinese authorities have previously approved four vaccines for mass use, including three inactivated ones developed by Beijing Kexing Zhongwei Biotechnology (part of Sinovac), the Wuhan Research Institute of Biological Products (Sinopharm structure), and China National Biotech Group (part of Sinopharm). Also, the only recombinant vaccine against COVID-19 based on the Ad5-nCoV adenovirus vector from CanSino Biologics has been approved so far. Vaccination in China is carried out free of charge and voluntarily.